ClinicalTrials.Veeva

Menu

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

The University of Chicago logo

The University of Chicago

Status

Enrolling

Conditions

Sarcoidosis
Connective Tissue Disorder
Interstitial Lung Diseases
Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Other
NETWORK
NIH

Identifiers

NCT00470327
14163A
1R21AI126031-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Enrollment

4,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Interstitial lung disease

Exclusion criteria

  • Does not have Interstitial lung disease

Trial contacts and locations

1

Loading...

Central trial contact

Vanita Patel, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems